This notice is a partial modification of an earlier notification, dated 15 April, which allowed urgent approval for all vaccines approved by top international regulators, including the US (FDA), Europe (EMA), UK (MHRA), Japan (PMDA) or which are listed in the World Health Organization’s Emergency Use Listing.